About MIS | Contact The Future of Prostate Spacing is Here A biodegradable injectable device for protection of the rectal wall when treating prostate cancer with radiation. BARRIGEL is approved for prostate rectum separation in Europe. BARRIGEL is CE-Marked and indicated for prostate spacing The prostate spacing market first published with Non-Animal Stabilised Hyaluronic Acid (NASHA®) in 2007 More than 2,500 RT patients have been treated with NASHA Barrigel is the Next Generation Spacer NASHA the Proven Solution BARRIGEL is the first commercially available hyaluronic acid (HA) spacer NASHA has a long history of safety, efficacy and biocompatibility Over 40 million treatments with NASHA NASHA puts you in Control No polymerisation or hardening, allowing unrestricted time for injection quality assurance Gel viscosity remains uniform and consistent to sculpt the space Uniform distribution for desired sculpted space and volume Moving to BARRIGEL is an easy Transition BARRIGEL is packaged for immediate use in a single syringe 7 1. No preparation is required (patient ready, single pre-filled syringe) 2. No shaking is required 3. No waiting is required 4. No time constraints BARRIGEL Patient Brochure A GLOBAL FIRST FOR NNUH! Norfolk and Norwich University Hospital Brachytherapy Team have become the first team globally to insert BARRIGEL® (Hyaluronic Acid... Home About Imaging Oncology News Careers Barrigel PACS Support Education Follow Call Staff Log In 0208 205 9500 Back to top © 2015 MIS Healthcare, Colindale, London, UK | Medical Imaging Systems Limited | ICO Registered ZA353845 (Privacy Policy) (Cookie Policy) (Modern Slavery)

About MIS | Contact Mammography Giotto Class 3000 Giotto Class 4000 WorkstationOne Home About Imaging Oncology News Careers Barrigel PACS Support Education Follow Call Staff Log In 0208 205 9500 Back to top © 2015 MIS Healthcare, Colindale, London, UK | Medical Imaging Systems Limited | ICO Registered ZA353845 (Privacy Policy) (Cookie Policy) (Modern Slavery)